MedTrace Logo

Accuracy Characterization Study

NCT01932944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-01-24

No results posted yet for this study

Summary

To demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring System (System) interstitial glucose results against venous glucose reference and capillary fingerstick using the Consensus Error Grid over the wear duration. During the course of the wear duration, the subject is required to be testing fingerstick glucose measurement at least 8 times a day for capillary reference glucose measurements and three in-clinic visits of maximum 10 hours each for venous reference glucose measurements. With every reference measurement, the subject or study staff will perform a measurement on the System.

Conditions

  • Type2 Diabetes
  • Type1diabetes
  • Insulin Dependent Diabetes

Interventions

DEVICE

No treatment

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Mark Christiansen, M.D. · Diablo Clinical Research

  • Leslie Klaff, M.D. · Rainier Clinical Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-10-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01932944 on ClinicalTrials.gov